🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Novavax Jumps While J&J Falls on Vaccine News

Published 01/30/2021, 01:34 AM
Updated 01/30/2021, 01:43 AM
©  Reuters
DJI
-
JNJ
-
GME
-
NVAX
-
AMC
-

By Liz Moyer

Investing.com -- GameStop Corp (NYSE:GME) and AMC Entertainment Holdings Inc (NYSE:AMC) aren't the only hot stocks on Friday. Novavax Inc (NASDAQ:NVAX) jumped 65% after its Covid-19 vaccine candidate showed 89.3% effectiveness in a U.K. trial.

That compares to the 72% efficacy shown in a U.S. trial of Johnson & Johnson (NYSE:JNJ)'s vaccine candidate. Shares of J&J fell 4.6%. J&J said its candidate showed less effectiveness in trials outside the U.S.

Still, the prospect of two more vaccines coming to market soon should be good news for markets in general, though they weren't acting like it on Friday. The Dow Jones Industrial Average was down more than 600 points as of midday. 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.